CHECK CAP LTD (CHEK)

IL0011336851 - Common Stock

2.25  +0.03 (+1.35%)

Fundamental Rating

2

CHEK gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 195 industry peers in the Health Care Equipment & Supplies industry. While CHEK has a great health rating, there are worries on its profitability. CHEK has a expensive valuation and it also scores bad on growth.



0

1. Profitability

1.1 Basic Checks

CHEK had negative earnings in the past year.
CHEK had a negative operating cash flow in the past year.
CHEK had negative earnings in each of the past 5 years.
In the past 5 years CHEK always reported negative operating cash flow.

1.2 Ratios

The Return On Assets of CHEK (-60.70%) is worse than 75.90% of its industry peers.
CHEK has a Return On Equity (-64.32%) which is in line with its industry peers.
Industry RankSector Rank
ROA -60.7%
ROE -64.32%
ROIC N/A
ROA(3y)-47.83%
ROA(5y)-71.77%
ROE(3y)-54.92%
ROE(5y)-93.63%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

CHEK does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

7

2. Health

2.1 Basic Checks

CHEK has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, CHEK has more shares outstanding
There is no outstanding debt for CHEK. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

CHEK has an Altman-Z score of -2.97. This is a bad value and indicates that CHEK is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -2.97, CHEK is not doing good in the industry: 63.59% of the companies in the same industry are doing better.
There is no outstanding debt for CHEK. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -2.97
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

CHEK has a Current Ratio of 17.60. This indicates that CHEK is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 17.60, CHEK belongs to the best of the industry, outperforming 98.97% of the companies in the same industry.
A Quick Ratio of 17.60 indicates that CHEK has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 17.60, CHEK belongs to the top of the industry, outperforming 98.97% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 17.6
Quick Ratio 17.6

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 14.35% over the past year.
EPS 1Y (TTM)14.35%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-1000%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Revenue growth Q2QN/A

3.2 Future

Based on estimates for the next years, CHEK will show a small growth in Earnings Per Share. The EPS will grow by 2.75% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-23.93%
EPS Next 2Y0.62%
EPS Next 3Y2.75%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CHEK. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CHEK. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.62%
EPS Next 3Y2.75%

0

5. Dividend

5.1 Amount

CHEK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CHECK CAP LTD

NASDAQ:CHEK (4/25/2024, 12:28:05 PM)

2.25

+0.03 (+1.35%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap13.16M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -60.7%
ROE -64.32%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 17.6
Quick Ratio 17.6
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)14.35%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-23.93%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y